Anduril's Pre-IPO Valuation: What the Numbers Mean

Anduril was marked at $61 billion in May 2026 and is reportedly in talks for more. Here is what the valuation reflects, why reported marks differ, and why a tokenized version trading on a blockchain is not the same number.

Share
Anduril's Pre-IPO Valuation: What the Numbers Mean

Anduril Industries, the defense technology company, was last valued at $61 billion in a $5 billion funding round in May 2026, led by Thrive Capital and Andreessen Horowitz, roughly double the $30.5 billion mark from its prior round, according to reporting by Bloomberg, CNBC and TechCrunch. In July 2026, the company was reported to be in talks to raise at roughly a $100 billion valuation, possibly structured in two stages. That is a reported negotiation, not a closed round or a confirmed valuation.

Key takeaways

  • Anduril's most recent confirmed valuation is $61 billion, set in its May 2026 round. The $100 billion figure is reported talks, not a closed deal.
  • Anduril is a private company. It has not filed for an IPO, confidentially or otherwise, so there is no public timeline or price.
  • Private valuations are marks: the price agreed in a specific funding round on a specific date, not a live market price that updates every second.
  • A token called "ANDURIL" trades on the Solana blockchain, but it is a wrapper issued by a third party, not company equity. Its market value (about $1.8 million) has no relationship to the $61 billion company valuation.
  • Secondary-market aggregators sometimes list higher marks (the aggregator Tracxn showed $111 billion as of September 1, 2026). These are third-party estimates, not confirmed figures.

What a private valuation actually is, and why it is not a stock price

When a company is public, its valuation is simple: the share price on the exchange, multiplied by the number of shares. It moves constantly and anyone can see it.

A private company like Anduril has no public share price. Its valuation comes from a funding round: investors buy newly issued shares at a negotiated price, and that price, multiplied by the total share count, produces the headline number. This is a point-in-time agreement between a buyer and a seller, closer to an appraisal than a live market quote. Anduril's $61 billion figure reflects what Thrive Capital, Andreessen Horowitz and co-investors agreed to pay in May 2026. It does not update daily and it does not mean you could sell a stake at that price today.

This matters because private valuations carry two features public prices do not. First, they are stale between rounds: a company can be worth very different amounts to different buyers in the months between financings. Second, the headline often reflects the price of preferred shares, which usually carry protections (liquidation preferences, for example) that ordinary common shares do not. So the "valuation" can overstate what a common shareholder would receive in a sale.

The reported numbers, dated and attributed

DateReported valuationWhat it wasSource
Prior round$30.5BEarlier $2.5B financing markReported (Bloomberg, CNBC, TechCrunch)
May 2026$61BClosed $5B round, led by Thrive and a16zReported (Bloomberg, CNBC, TechCrunch)
July 2026~$100BReported talks, possibly two-stage. Not closed.Reported talks
Sept 1, 2026$111BThird-party secondary aggregator estimate (Tracxn)Unverified aggregator mark

The only figure here that represents a completed transaction at an agreed price is the May 2026 round at $61 billion. The $100 billion is a reported negotiation. The $111 billion aggregator estimate is an inference drawn from secondary trading data, which can be thin and infrequent for a company this large. Treat each according to what it is.

The token that shares Anduril's name is not Anduril

You may come across an asset called "ANDURIL" trading on Solana, a blockchain (a shared public ledger that records transfers). This is a tokenized wrapper issued by a company called PreStocks, not a security issued by Anduril. Buying it does not give you company equity, shareholder rights, or voting rights. It is a separate instrument whose price is set by whoever is trading the token, not by Anduril's cap table.

The scale gap makes the distinction concrete. Anduril the company was marked at $61 billion. The ANDURIL token's entire market value is about $1.83 million, with roughly 11,286 holders and $3.64 million in transfer volume over 30 days (Allium data, retrieved October 12, 2026). These are two unrelated numbers. The token's price does not discover the company's worth, and the company's valuation does not flow back to the token.

One quirk is worth noting. Among the tokenized pre-IPO names tracked on Solana, ANDURIL has more holders than tokens tied to Oura or Figure AI, yet far less trading volume than the tokens named for the large AI labs. In other words, a lot of wallets hold a little, and they trade it infrequently. That is a fact about the wrapper's trading behaviour, not a signal about Anduril's business.

Why the onchain figures are hard to read, and what fixes it

Suppose you wanted to compare how actively these pre-IPO wrappers trade, ANDURIL against the tokens named for the AI labs, prediction-market firms, or Neuralink. The raw blockchain records do not make this easy. Each transfer arrives as a low-level log: a token contract address, two wallet addresses, and a raw amount, with no human-readable issuer, no asset label, and no dollar value attached. To line nine assets up in one table, every transfer has to resolve to the same fields: asset, issuer, sender, recipient, amount, USD value, and transaction type. Allium normalizes those records across 150+ blockchains into that consistent shape, which is what lets the volume, holder, and market-cap figures above sit side by side. That is a read layer on public data, not a venue, broker, or source of investment advice.

What to watch, and what is unresolved

Anduril has not filed for an IPO. Unlike companies such as Anthropic, OpenAI and Oura, which have confidentially filed registration statements with the U.S. Securities and Exchange Commission, Anduril is not in the SEC registration process as of this writing. There is no public pricing range, no listing venue, and no timeline to speak of.

The open questions for anyone tracking the valuation are straightforward. Does the reported $100 billion negotiation close, and at what structure? Do secondary marks (the $111 billion aggregator figure) converge with or diverge from the primary round price? And for the tokenized wrappers more broadly, the legal and regulatory treatment of instruments that reference private-company value without conferring equity remains unsettled across jurisdictions. None of that is resolved today, and none of it is investment advice.

If you are looking at how private marks get established and tested before any public listing, two adjacent explainers go deeper: on whether you can price an IPO before the IPO, and on how pre-IPO shares actually change hands through tender offers and secondaries.

Frequently asked questions

What is Anduril's current valuation?

Anduril's most recent confirmed valuation is $61 billion, set in a $5 billion funding round in May 2026 led by Thrive Capital and Andreessen Horowitz, roughly double its prior $30.5 billion mark. In July 2026 it was reported to be in talks to raise at about $100 billion, but that is a reported negotiation, not a closed round or a confirmed figure.

Has Anduril filed for an IPO?

No. As of this writing, Anduril has not filed for an IPO, confidentially or publicly, and is not in the SEC registration process. There is no public pricing, listing venue, or timeline. Any reporting that implies a specific IPO date is speculation.

Can I buy Anduril shares before the IPO?

Anduril is a private company, so its shares are not traded on a public exchange. Access to private shares is typically limited to employees, early investors, and participants in secondary transactions, often restricted to accredited investors. A token named ANDURIL on the Solana blockchain is a third-party wrapper, not Anduril equity, and holding it confers no shares, voting rights, or shareholder rights.

Why do different sources show different Anduril valuations?

Private valuations are point-in-time marks, not live prices. The $61 billion figure comes from a completed May 2026 funding round. The $100 billion figure is reported talks. Higher marks from secondary aggregators (such as $111 billion dated September 1, 2026) are third-party estimates inferred from secondary trading, which can be thin. Each number reflects a different method and date.

Does the ANDURIL token on Solana track the company's valuation?

No. The token is a wrapper issued by PreStocks, with a total market value of roughly $1.83 million as of October 2026. Anduril the company was marked at $61 billion. The two numbers are unrelated. The token's price is set by its own traders and does not discover or reflect the company's actual worth.

What is the difference between a private valuation and a stock price?

A public stock price is a live market quote that updates continuously and reflects what any buyer and seller will transact at. A private valuation is a negotiated mark from a specific funding round on a specific date. It does not update daily, often reflects preferred shares with special protections, and does not guarantee you could sell at that price today.


Interested in learning more about Allium’s pre-IPO and private market data? Speak to someone on the team.


Allium provides onchain data infrastructure. Companies named in this article may be Allium customers, prospects or commercial counterparties. The authors and other Allium personnel may hold positions in the assets discussed. This article is informational only and is not investment, legal or tax advice. Data and information last reviewed: October 12, 2026.